Abstract：[Abstract] Objective: To investigate the inhibition of 5-Aza-2′ deoxycytidine (5-Aza-dC) on human lung adenocarcinoma cell line A549 and its possible mechanism.Methods: Use MTT method to find the differences of the effect on A549 cell growth; use Coomassie Brilliant Blue G-250 staining to determine the relative protein content of the tested A549 cell; use Hoechst 33258 fluorescence staining to observe the apoptosis of A549 cell and its morphological variations. Results：When the 5-Aza-dC was given in a certain range of concentration(40-100 μg／mL),the A549 cell proliferation could be significantly inhibited in a dose and time manner, compared with the control group(P<0.05, P<0.01). Meanwhile, the relative content of protein in the tested A549 cell was significantly decreased. When the concentration was in the range of 60-100 μg／mL, the apoptosis of A549 cell and its morphological variations could be observed. Conclusion： 5-Aza-dC can inhibit the growth of human lung adenocarcinoma A549 cells, induce the apoptosis and decrease the relative content of the protein. Its mechanism can be related to the block of cell cycle, alternation of the protein function and apoptosis induction.
收稿日期: 2012-10-09
基金资助:
江苏大学大学生科研立项资助项目（11A302）
通讯作者:
端礼荣，副教授，E-mail：duanlr@ujs.edu.cn
作者简介: 李婧（1992—），女，江苏镇江人；
引用本文:
李婧, 顾颖超, 陈圆圆, 端礼荣. 5-氮杂-2′-脱氧胞苷对人肺腺癌A549细胞株的生长抑制作用[J]. 江苏大学学报:医学版, 2013, 23(4): 304-307.
LI Jing, GU Ying-chao, CHEN Yuan-yuan, DUAN Li-rong.
Growth inhibition of 5-Aza-2′-deoxycytidine on human lung adenocarcinoma cell line A549. Journal of Jiangsu University(Medicine Edition), 2013, 23(4): 304-307.
[1]Raynal NJ, Charbonneau M, Momparler LF, et al. Synergistic effect of 5-Aza-2′-deoxycytidine and genistein in combination against leukemia［J］. Oncol Res， 2008, 17(5): 223-230［2］Miremadi A, Oestergaard MZ, Pharoah PD, et al. Cancer gentics of epigenetic genes［J］. Hum Mol Genet， 2007, 16(1): R28-49［3］Boland CR, Shin SK, Goel A. Promote rmethylation in the genesis of gastrointestinal cancer［J］. Yonsei Med J, 2009, 50(3): 309-321［4］Ecke L，Petry F, Rosenberger A, et al. Antitumor effectsofa combined 5-Aza-2′deoxycytidine and valproic acid treatment on rhabdomyosarcoma and medulloblastoma in Ptch mutant mice［J］. Cancer Res, 2009, 69(3): 887-895［5］Lemaire M, Momparler LF, Bernstein ML, et al. Enhancement of antineoplastic action of 5-Aza-2′-deoxycytidine by zebularine on L1210 leukemia［J］. Anticancer Drugs, 2005, 16(3): 301-308［6］Lemaire M, Momparler LF, Raynal NJ, et al. Inhibition of cytidine deaminase by zebularine enhances the antineoplastic action of 5-aza-2′-deoxycytidine［J］. Cancer Chemother Pharmacol, 2009, 63(3): 411-416
2013, Vol. 23 
